CC Insider Filing: Chief Accounting Officer Withholds 2,374 Shares for Taxes

Rhea-AI Filing Summary

The Chemours Company (CC) reporting person Will David, identified as the company's Chief Accounting Officer, reported a routine tax-withholding transaction tied to vested restricted stock units and dividend equivalent units. On 08/12/2025 2,374 shares were withheld at a price of $12.42 to satisfy tax obligations; no shares were sold and the transaction is exempt under Rule 16b-3. After the withholding, Mr. David beneficially owns 25,189.8011 shares (direct ownership). The filing includes a Power of Attorney as Exhibit 24 and was signed by an attorney-in-fact on 08/14/2025.

Positive

• Proper disclosure of the withholding transaction with transaction code F and explanatory remarks
• Transaction exempt under Rule 16b-3, indicating it was an administrative tax-withholding on vested awards rather than an open-market sale
• Power of Attorney attached as Exhibit 24 and form signed by attorney-in-fact, showing filing formalities were followed

Negative

• None.

Insights

Financial Analyst

TL;DR: Routine tax-withholding on vested equity; minor change in reported holdings, no sales, no unusual trading activity.

The Form 4 discloses an internal tax-related withholding of 2,374 shares tied to vested restricted stock units and dividend equivalents at $12.42 per share. Such transactions are typically administrative and exempt under Rule 16b-3, indicating these were not discretionary open-market sales. The post-transaction beneficial ownership is 25,189.8011 shares direct, which is a small-scale holding change for an officer and unlikely to affect company control or signal a material change in insider sentiment.

Corporate Governance Expert

TL;DR: Filing reflects routine equity compensation mechanics with appropriate disclosures and Power of Attorney attached.

The report properly identifies the reporting person and relationship (Chief Accounting Officer), lists the withholding as transaction code F with explanatory remarks, and cites Rule 16b-3 exemption. The presence of a Power of Attorney exhibit and attorney-in-fact signature indicates compliance with filing formalities. There are no disclosures of derivative exercises, open-market transactions, or departures that would raise governance concerns.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Will David

(Last) (First) (Middle)

C/O THE CHEMOURS COMPANY

1007 MARKET STREET

(Street)

WILMINGTON DE 19801

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Chemours Co [ CC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Accounting Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/12/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/12/2025		F(1)		2,374	D	$12.42	25,189.8011(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares automatically withheld to satisfy tax obligations on vesting restricted stock units and dividend equivalent units. Transactions are exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold.

2. Includes restricted stock units and dividend equivalent units.

Remarks:

Power of Attorney attached as Exhibit 24.

	/s/ Eric Stein, Attorney-in-Fact	08/14/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Will David report on the Form 4 for Chemours (CC)?

He reported that 2,374 shares were withheld to satisfy tax obligations on vested restricted stock units and dividend equivalent units on 08/12/2025 at a price of $12.42 per share.

Did the Form 4 report any open-market sales by the reporting person?

No. The filing states no shares were sold and the transaction was a withholding to satisfy taxes.

What is the reporting person's relationship to Chemours (CC)?

The reporting person, Will David, is identified as an Officer with the title Chief Accounting Officer.

How many shares does Will David beneficially own after the transaction?

Following the withholding, he beneficially owns 25,189.8011 shares (reported as direct ownership).

Is this transaction considered a Section 16(b) short-swing transaction?

No. The filing notes the transactions are exempt from Section 16(b) pursuant to Rule 16b-3 as they relate to tax withholding on vested awards.